Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Cawood

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|December 8, 2023
AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genesWeiheng Su, Leonard W Seymour, Ryan Cawood
Current Opinion in Molecular Therapeutics|August 3, 2010
Blood compatibility of enveloped virusesGray Kueberuwa, Ryan Cawood, Leonard W Seymour
Genome Biology|January 30, 2008
Toward more effective gene deliveryHannah H Chen, Ryan Cawood, Leonard W Seymour
Current Opinion in Molecular Therapeutics|August 7, 2008
Cellular carriers or free viruses?Leonard W Seymour, Ryan Cawood, Kerry D Fisher
Human Gene Therapy Methods|February 27, 2014
Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stabilityGray Kueberuwa, Ryan Cawood, Alison Tedcastle, et al.
Drug Discovery Today|December 27, 2011
Virotherapy--cancer targeted pharmacologyAlison Tedcastle, Ryan Cawood, Ying Di, et al.
Plos One|January 26, 2011
MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activityRyan Cawood, Suet-Ling Wong, Ying Di, et al.
Cell Cycle (Georgetown, Tex.)|April 12, 2007
Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid proteinRyan Cawood, Sally M Harrison, Brian K Dove, et al.
Molecular Therapy. Methods & Clinical Development|June 16, 2025
Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectorsChloé Fustinoni, Xiang Liu, Zhi Chen, et al.
Plos One|November 19, 2016
A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell ActivationThomas Hills, Phillip G Jakeman, Robert C Carlisle, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|December 8, 2023
AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genesWeiheng Su, Leonard W Seymour, Ryan Cawood
Current Opinion in Molecular Therapeutics|August 3, 2010
Blood compatibility of enveloped virusesGray Kueberuwa, Ryan Cawood, Leonard W Seymour
Genome Biology|January 30, 2008
Toward more effective gene deliveryHannah H Chen, Ryan Cawood, Leonard W Seymour
Current Opinion in Molecular Therapeutics|August 7, 2008
Cellular carriers or free viruses?Leonard W Seymour, Ryan Cawood, Kerry D Fisher
Human Gene Therapy Methods|February 27, 2014
Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stabilityGray Kueberuwa, Ryan Cawood, Alison Tedcastle, et al.
Drug Discovery Today|December 27, 2011
Virotherapy--cancer targeted pharmacologyAlison Tedcastle, Ryan Cawood, Ying Di, et al.
Plos One|January 26, 2011
MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activityRyan Cawood, Suet-Ling Wong, Ying Di, et al.
Cell Cycle (Georgetown, Tex.)|April 12, 2007
Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid proteinRyan Cawood, Sally M Harrison, Brian K Dove, et al.
Molecular Therapy. Methods & Clinical Development|June 16, 2025
Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectorsChloé Fustinoni, Xiang Liu, Zhi Chen, et al.
Plos One|November 19, 2016
A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell ActivationThomas Hills, Phillip G Jakeman, Robert C Carlisle, et al.
Pageof 3